November 17, 2024
As the cost of bringing a new health technology to market continues to climb, more and more firms, developers, and investors are searching for tools to prioritize their efforts on the technologies with the greatest potential for clinical impact and market viability.
While health economic analysis has long been established as a necessity to inform decision making for market access and reimbursement, it is increasingly being used at earlier stages of product development for healthcare and life sciences to increase the access rate of R&D and efficiently prioritize data collection. The number of available methods for this field has continued to expand.
Enroll into this course to:
- Demystify the objectives of early-stage health technology assessment and the methods of translational health economics.
- Gain a thorough understanding of available methods for early-stage technology assessment.
- Explore the specific challenges and solutions for early-stage technology assessment.
- Gain a clear sense of how to implement early-stage health technology assessments in the complexity of health technology development, funding, regulation, pricing, and reimbursement.
Through this course you will have the opportunity to utilize real-world examples and strategize about the creation of a research plan.
This short course is offered in-person at the ISPOR Europe 2024 conference.
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
LEVEL: Introductory
TRACK: Health Technology Assessment
HEOR Key Competency: 9.1 Global Understanding of Health Systems and HTA
LENGTH: 4 Hours | Course runs 1 day
FACULTY MEMBERS
Schedule:
Sunday, 17 November 2024 | Course runs 1 Day
08:00-12:00 Central European Time (CET)
Register Here
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
Visit the ISPOR Europe 2024 Program page to view all short courses offered.